Dropout from guideline-recommended psychological treatments for posttraumatic stress disorder: A systematic review and meta-analysis

• Published in: Journal of affective disorders reports Vol. 4; p. 100093
• Main Authors: Varker, Tracey, Jones, Kimberley A., Arjmand, Hussain-Abdulah, Hinton, Mark, Hiles, Sarah A., Freijah, Isabella, Forbes, David, Kartal, Dzenana, Phelps, Andrea, Bryant, Richard A., McFarlane, Alexander, Hopwood, Malcolm, O'Donnell, Meaghan
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.04.2021; Elsevier
• Subjects: Dropout; Guidelines; Meta-analysis; Psychiatric/Mental Health; PTSD; Treatment; PTSD; Treatment; Dropout; Guidelines; Meta-analysis
• ISSN: 2666-9153; 2666-9153
• DOI: 10.1016/j.jadr.2021.100093

•Only 7% of treatment trials operationally define dropout.•The dropout rate for guideline recommended psychological PTSD treatments is 20.9%.•Dropout by military and veteran populations was higher than for civilians. Many patients drop out of guideline-recommended treatments for posttraumatic stress disorder (PTSD), yet there has been little systematic investigation of this issue. We aimed to examine dropout proportions from randomized controlled trials (RCTs) of guideline-recommended treatments for PTSD and whether proportions differed by type of treatment or trauma, PTSD severity or chronicity, or medication being permitted. Systematic review and meta-analysis of RCTs of guideline-recommended treatments for PTSD. Eighty-five trials, with data for 6804 participants were included in the meta-analyses. The mean dropout proportion for guideline-recommended treatment was 20.9% (95%CI 17.2, 24.9) with evidence of high heterogeneity across studies. Military trauma was associated with higher dropout than civilian trauma. The civilian trauma group had similar dropout rates from guideline-recommended treatments, and active, waitlist or treatment as usual controls. In the military trauma group, dropout was higher from guideline-recommended treatments compared to active, waitlist or treatment as usual controls. Within this group, dropout from trauma-focused treatment was significantly higher than from non-trauma focused treatments overall, with the greatest difference in dropout rates occurring between randomization and treatment initiation. Most RCTs exclude participants who have comorbid substance use disorder, suicidal behaviour, or history of psychosis, which limits the generalizability of findings. Dropout from guideline-recommended treatment for PTSD is higher in populations who have experienced military trauma and this population dropout from treatment in higher proportions when it is trauma-focused. The reasons for disparate rates of dropouts from recommended PTSD treatments require further investigation.